PO-099: The Prognostic Importance of Molecular-Genetics and Morphological Factors in Prognosis of Recurrent HNSCC by Kutukova, S.I, Yaremenko, A.I, Manikhas, G.M, Dibirov, R.K

Get full text

PO-122: The Prognostic Role of Epidemiological Factors in Prognosis of Recurrent HNSCC by Kutukova, S, Yaremenko, A.I, Ermakova, T.S, Manikhas, G.M

Get full text

PO-059: The Role of Tumour Markers and Clinico-Laboratories Result in Prognosis of Relapse Oral Squamous Cell Carcinoma by Kutukova, S.I, Yaremenko, A.I, Manikhas, G.M, Bozhor, S.S

Get full text

5060 POSTER Albumin-bound Paclitaxel (ab-pac) Versus Docetaxel for First-line Treatment of Metastatic Breast Cancer (MBC): Overall Survival (OS) Subset Analyses of a Randomized Pha... by Gradishar, W.J, Krasnojon, D.A, Cheporov, S.V, Makhson, A.N, Manikhas, G.M, Clawson, A, Bhar, P

Get full text

3541 POSTER HER2-positive advanced gastric cancer: similar HER2-positivity levels to breast cancer by Lordick, F, Bang, Y.J, Kang, Y.K, Otero Reyes, D, Manikhas, G.M, Shen, L, Kulikov, E, Stoss, O, Jordan, B.W.M, van Cutsem, E

Get full text

2108 POSTER Cardiac safety of trastuzumab in combination with epirubicin/ cyclophosphamide as first-line therapy in patients with HER2-positive metastatic breast cancer by Untch, M, Tjulandin, S, Jonat, W, Meerpohl, H, Lichinitser, M, Manikhas, G.M, Jänicke, F, Muscholl, M, Pauschinger, M, Lehle, M

Get full text

2030 ORAL Efficacy of neoadjuvant trastuzumab in patients with inflammatory breast cancer: data from the NOAH ( N e OA djuvant Herceptin) Phase III trial by Baselga, J, Semiglazov, V, Manikhas, G.M, Eiermann, W, Lluch, A, Tjulandin, S, Feyereislova, A, Vanhauwere, B, Valagussa, P, Gianni, L

Get full text

The benefit of endoscopic metastasectomy compared to open surgery in advanced renal cell carcinoma (mRCC). Results of a multicentre retrospective trial by Borisov, P., Orlova, R.V., Shkolnik, M.I., Manikhas, G.M., Karlov, P.A.

Get full text

15 - The benefit of endoscopic metastasectomy compared to open surgery in advanced renal cell carcinoma (mRCC). Results of a multicentre retrospective trial by Borisov, P., Orlova, R.V., Shkolnik, M.I., Manikhas, G.M., Karlov, P.A.

Get full text